Literature DB >> 11049734

Peripheral actions of tachykinins.

A Lecci1, S Giuliani, M Tramontana, F Carini, C A Maggi.   

Abstract

Tachykinins mediate a variety of physiological processes in the gastrointestinal, pulmonary and genito-urinary tract mainly through the stimulation of NK1 and NK2 receptors. Preclinical evidence obtained through the use of selective tachykinin receptor antagonists indicates that endogenous tachykinins are involved in augmented smooth muscle contraction, vasodilatation, chemotaxis and activation of immune cells, mucus secretion, water absorption/secretion. Recent evidence also suggests that endogenous tachykinins released at the peripheral level may play a role in visceral inflammation, hyperreflexia and hyperalgesia. Possible mechanisms underlying the stimulation of primary afferent neurons by tachykinins may involve a direct excitation of these neurons and the release of mediators which sensitise or stimulate sensory nerves. Tachykinin receptor antagonists could have a clinical utility in several human diseases such as irritable bowel syndrome, asthma, and in micturition disturbances characterized by a hyperactive bladder. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049734     DOI: 10.1054/npep.2000.0825

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  7 in total

1.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 2.  Status of immune mediators in complex regional pain syndrome type I.

Authors:  Christian Schinkel; Martin H Kirschner
Journal:  Curr Pain Headache Rep       Date:  2008-06

3.  The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum.

Authors:  Ryosuke Takahashi; Junji Nishimura; Katsuya Hirano; Seiji Naito; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Role of tachykinins in the host response to murine gammaherpesvirus infection.

Authors:  C M Payne; C J Heggie; D G Brownstein; J P Stewart; J P Quinn
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Tachykinins and tachykinin receptors in human uterus.

Authors:  Eva Patak; M Luz Candenas; Jocelyn N Pennefather; Sebastian Ziccone; Alison Lilley; Julio D Martín; Carlos Flores; Antonio G Mantecón; Margot E Story; Francisco M Pinto
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 6.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

7.  Ovarian steroids regulate tachykinin and tachykinin receptor gene expression in the mouse uterus.

Authors:  Francisco M Pinto; C Oscar Pintado; Jocelyn N Pennefather; Eva Patak; Luz Candenas
Journal:  Reprod Biol Endocrinol       Date:  2009-07-23       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.